Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Treatment for Intermediate-Risk Relapse of Childhood B-precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies

NCT00381680 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00381680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00381680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Treatment for Intermediate-Risk Relapse of Childhood B-precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies
Lead sponsor
Children's Oncology Group
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2007
Completion date
Not reported
Enrollment
275 (actual)
Sites
173

Conditions

As the registry lists them; a condition with its own page is linked.

b-cell childhood acute lymphoblastic leukemia, intermediate risk recurrent childhood acute lymphoblastic leukemia, l1 childhood acute lymphoblastic leukemia, l2 childhood acute lymphoblastic leukemia